No Role for Triple Antiplatelet Therapy?

被引：2
作者：
Antoniucci, David [1 ]
机构：
[1] Careggi Hosp, Div Cardiol, I-50139 Florence, Italy
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 03期
关键词：
cilostazol; DES; platelet reactivity; MAINTENANCE-DOSE CLOPIDOGREL; ELUTING STENT IMPLANTATION; OF-CARE ASSAY; PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; CILOSTAZOL; INHIBITION; TRIAL; AGGREGATION; EVENTS;
D O I：
10.1016/j.jacc.2010.08.632
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：290 / 291
页数：2
相关论文
共 50 条
  • [31] Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits?
    Asencio, Luis Alejandro
    Huang, Jennifer J.
    Alpert, Joseph S.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (07) : 579 - 585
  • [32] The role of antiplatelet therapy in the secondary prevention of coronary artery disease
    Behan, Miles W.
    Chew, Derek P.
    Aylward, Philip E.
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) : 321 - 328
  • [33] Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials
    Bundhun, Pravesh Kumar
    Qin, Tao
    Chen, Meng-Hua
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [34] Triple antiplatelet therapy with cilostazol: Hitting the "Sweet-Spot"
    Belardi, Jorge A.
    Albertal, Mariano
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (01) : 50 - 51
  • [35] The Role of Antiplatelet Therapy in Patients With MINOCA
    Ortega-Paz, Luis
    Galli, Mattia
    Capodanno, Davide
    Brugaletta, Salvatore
    Angiolillo, Dominick J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [36] Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
    Bowman, Stephanie
    Gass, Jennifer
    Weeks, Phillip
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (02) : 171 - 177
  • [37] Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy
    Horie, Nobutaka
    Kaminogo, Makio
    Izumo, Tsuyoshi
    Hayashi, Kentaro
    Tsujino, Akira
    Nagata, Izumi
    NEUROLOGICAL RESEARCH, 2015, 37 (07) : 619 - 623
  • [38] Clinical Implications of "Tailored" Antiplatelet Therapy in Patients With Chronic Total Occlusion
    De Gregorio, Maria Grazia
    Marcucci, Rossella
    Migliorini, Angela
    Gori, Anna Maria
    Giusti, Betti
    Vergara, Ruben
    Paniccia, Rita
    Carrabba, Nazario
    Marchionni, Niccolo
    Valenti, Renato
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (04):
  • [39] Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis
    Zhou, Hong
    Feng, Xiao-Ling
    Zhang, Hong-Ying
    Xu, Fei-Fei
    Zhu, Jie
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (04) : 1034 - 1040
  • [40] Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status
    Capranzano, Piera
    Ferreiro, Jose Luis
    Ueno, Masafumi
    Capodanno, Davide
    Dharmashankar, Kodlipet
    Darlington, Andrew
    Desai, Bhaloo
    Tello-Montoliu, Antonio
    Rollini, Fabiana
    Angiolillo, Dominick J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (01) : 42 - 49
12345